Comparative genome-scale analysis of gene expression profiles in T cell lymphoma cells during malignant progression using a complementary DNA microarray

American Journal of Pathology

Volumn 158, Issue 4, 2001, Pages 1231-1237

  Li, Shiyong ^a,d   Ross, Douglas T ^b   Kadin, Marshall E ^c   Brown, Patrick O ^b   Wasik, Mariusz A ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; RNA;

APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER RESISTANCE; CANCER STAGING; CELL ACTIVATION; CELL ADHESION; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; DNA MICROARRAY; GENE EXPRESSION; HUMAN; HUMAN CELL; LYMPHOMA CELL LINE; NORTHERN BLOTTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SKIN LYMPHOMA; T CELL LYMPHOMA;

EID: 0035074541     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64073-4     Document Type: Article

References (38)

1. Transformation of mycosis fungoides/Sezary syndrome: Clinical characteristics and prognosis
2. Overexpression of p53 protein in cutaneous T cell lymphoma: Relationship to large cell transformation and disease progression
3. (INK4a) gene alterations are frequent in lesions of mycosis fungoides
4. Quantitative monitoring of gene expression patterns with a complementary DNA microarray
5. Use of a cDNA microarray to analyse gene expression patterns in human cancer
6. The transcriptional program in the response of human fibroblasts to serum
7. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring
8. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
9. Systematic variation in gene expression patterns in human cancer cell lines
10. A gene expression database for the molecular pharmacology of cancer
11. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia
12. Molecular portraits of human breast tumours
13. Hodgkin’s disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone
14. Analysis of IL-2, IL-4, and their receptors in clonally-related cell lines derived from a patient with a progressive cutaneous T-cell lymphoproliferative disorder
15. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome
16. Differences in phosphorylation of the IL-2R associated Jak/STAT proteins between HTLV-1(+), IL-2 independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia
17. The (2;5)(p23;q35) translocation in cell lines derived from malignant lymphomas: Absence of t(2;5) in Hodgkin-analogous cell tines
18. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin’s lymphoma
19. Recent results on the biology of Hodgkin and Reed-Sternberg cells. II. Continuous cell lines
20. Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter
21. The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo: A potential approach to prevention and treatment of posttransplant lymphoproliferative disorders
22. The hallmark of cancer
23. Serum midkine levels are increased in patients with various types of carcinomas
24. Midkine expression in Reed-Sternberg cells of Hodgkin’s disease
25. Molecular nature of a celt membrane antigen specific for human T-cell acute lymphoblastic leukemia
26. Cloning and expression analysis of human bleomycin hydrolase, a cysteine proteinase involved in chemotherapy resistance
27. CD45 regulated tyrosine phosphorylation of CD22 and its association with the protein tyrosine phosphatase SHP-1
28. The tyrosine phosphatase PTP1C associates with Vav, Grb2, and mSos1 in hematopoietic cells
29. Cytoplasmic domain mutants of beta1 integrin, expressed in beta 1-knockout lymphoma cells, have distinct effects on adhesion, invasion and metastasis
30. Expression of beta-integrin adhesion molecules in non-Hodgkin’s lymphoma: Correlation with clinical and evolutive features
31. Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt’s lymphoma underlies tumor cell escape from virus-specific T cell surveillance
32. Non-Hodgkin’s lymphoma in pediatric patients with chromosomal breakage syndromes (AT and NBS): Experience from the BFM trials
33. Ly-GDI, a GDP-dissociation inhibitor of the Rho GTP-binding protein, is expressed preferentially in lymphocytes
34. GDP dissociation inhibitor D4-GDI (Rho-GDI2), but not the homologous GDI 1, is cleaved by caspase-3 during drug-induced apoptosis
35. D4-GDI, a substrate of CPP32, is proteolyzed during Fas-induced apoptosis
36. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
37. Inhibition of ras-induced proliferation and cellular transformation by p16INK4
38. Loss of p16/INK4A protein expression in non-Hodgkin’s lymphomas is a frequent finding associated with tumor progression